SaNOtize Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $24M

  • Investors
  • 10

SaNOtize General Information

Description

Developer of a nitric oxide-releasing technology designed to treat upper respiratory and dermal infections. The company's technology provides first-line non-antibiotic antimicrobials for use against bacteria, viruses and fungi, helping medical industry professionals to treat a broad spectrum of infectious pathogens and topical infections.

Contact Information

Website
www.sanotize.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ash Street
  • Suite 1-8755
  • Vancouver, British Columbia V6P 6T3
  • Canada
+1 (855)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Ash Street
  • Suite 1-8755
  • Vancouver, British Columbia V6P 6T3
  • Canada
+1 (855)

SaNOtize Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SaNOtize Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 24-Aug-2022 $24M Completed Generating Revenue
7. Early Stage VC 01-Dec-2021 Completed Clinical Trials - Phase 3
6. Early Stage VC (Series A) 01-Aug-2021 Completed Clinical Trials - Phase 2
5. Grant 31-Dec-2020 Completed Clinical Trials - Phase 2
4. Equity Crowdfunding Completed Generating Revenue
3. Grant 05-Jun-2020 Completed Clinical Trials - Phase 2
2. Seed Round 29-Feb-2020 $2.45M $2.65M Completed Clinical Trials - Phase 1
1. Angel (individual) 01-May-2018 $200K $200K Completed Clinical Trials - Phase 1
To view SaNOtize’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

SaNOtize Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nitric oxide-releasing technology designed to treat upper respiratory and dermal infections. The company'
Drug Discovery
Vancouver, Canada
15 As of 2022

Aberdeen, United Kingdom
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SaNOtize Competitors (76)

One of SaNOtize’s 76 competitors is NovaBiotics, a Venture Capital-Backed company based in Aberdeen, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
Naked Biome Formerly VC-backed San Francisco, CA
Visterra Formerly VC-backed Waltham, MA
CytoAgents Venture Capital-Backed Pittsburgh, PA
Attune Pharmaceuticals Venture Capital-Backed New York, NY
You’re viewing 5 of 76 competitors. Get the full list »

SaNOtize Patents

  • 59

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 34

    Pending

  • Expiring in next 12 mo

SaNOtize Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3192725-A1 Dual-chamber spray device Pending 16-Sep-2020
AU-2021344727-A1 Dual-chamber spray device Pending 16-Sep-2020
EP-4126136-A1 Dual-chamber spray device Pending 16-Sep-2020
EP-4126136-A4 Dual-chamber spray device Pending 16-Sep-2020
CA-3186075-A1 Methods of treating conditions responsive to nitric oxide therapy Pending 16-Jul-2020 A61K33/00
To view SaNOtize’s complete patent history, request access »

SaNOtize Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SaNOtize Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABC International (Vancouver) Corporation Minority
Horizons Ventures Venture Capital Minority
The Global Value Investment Portfolio Management Venture Capital Minority
Happiness Capital Corporate Venture Capital Minority
Impact Assets Impact Investing Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

SaNOtize FAQs

  • When was SaNOtize founded?

    SaNOtize was founded in 2017.

  • Where is SaNOtize headquartered?

    SaNOtize is headquartered in Vancouver, Canada.

  • What is the size of SaNOtize?

    SaNOtize has 15 total employees.

  • What industry is SaNOtize in?

    SaNOtize’s primary industry is Drug Discovery.

  • Is SaNOtize a private or public company?

    SaNOtize is a Private company.

  • What is the current valuation of SaNOtize?

    The current valuation of SaNOtize is .

  • What is SaNOtize’s current revenue?

    The current revenue for SaNOtize is .

  • How much funding has SaNOtize raised over time?

    SaNOtize has raised $32.7M.

  • Who are SaNOtize’s investors?

    ABC International (Vancouver), Horizons Ventures, The Global Value Investment Portfolio Management, Happiness Capital, and Impact Assets are 5 of 10 investors who have invested in SaNOtize.

  • Who are SaNOtize’s competitors?

    NovaBiotics, Naked Biome, Visterra, CytoAgents, and Attune Pharmaceuticals are some of the 76 competitors of SaNOtize.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »